openPR Logo
Press release

Global Squamous Non-small Cell Lung Cancer Market Projected to Grow at a Steady Pace During 2017 – 2025

12-20-2017 07:51 AM CET | Health & Medicine

Press release from: Transparency Market Research

Global Squamous Non-small Cell Lung Cancer Market Projected

Lung cancer can be broadly classified into two categories such as non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Non-small cell lung cancer can be further classified into adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Squamous non-small cancer develops from the cells lining the airways and is found near the center of the lungs in one of the main airways. Non-small cell lung cancer globally accounts for 85% to 90% of lung cancer, in which adenocarcinoma and squamous cell cancers are responsible for approximately 40% and 30%, respectively. Prominent symptoms of squamous non-small cell lung cancer include excessive coughing, wheezing and shortness of breath, chest pain, and occurrence of blood in sputum. Many physicians misunderstood this disease with collapsed lungs or pneumonia. The disease usually takes longer time to develop from confined tumors to invasive cancer. Primary diagnostic technique comprises sputum test, bronchoscopy, MRI scan, needle biopsy, and CT scan among others. In Australia, squamous non-small cell lung cancer is a common type of lung cancer accounting for 29% of total cases of lung cancer.

Read Report Overview @ https://www.transparencymarketresearch.com/squamous-non-small-cell-lung-cancer-market.html

A key factor leading to squamous non-small cell lung cancer is smoking. Besides smoking, secondary risk factors comprise family history, age, and occupational hazards such as minerals and metal dust or exposure to asbestos or radon. Cancer stage detection is a crucial aspect for deterring the patient’s treatment plan. Stage 1 detection is when the squamous cell cancer is small and confined to the lungs, and stage 4 detection is when the tumors have spread beyond tissues and organs near the lungs. Stages between 2 and 3 describe the conditions in between these two extremes. When the squamous non-small cell lung cancer spreads, it may travel to the liver, adrenal glands, bone, brain, and small intestine. Clinical trials and researches conducted by major players are the key growth attributors of the global squamous non-small cell lung cancer market. Some of the prominent pipelined drugs in the market include apatorsen from OncoGenex Pharmaceuticals, famitinib maleate by Jiangsu Hengrui Medicine Co., dacomitinib from Pfizer, etc.

Request for Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35720

Geographically, in terms of revenue and clinical trials are primarily contributed by the developed economic countries such as North America and European countries. Pertaining to government support, research funding and awareness among people with respect to Request to view table of content @squamous non-small cell lung cancer are some of the key drivers for the developed economic countries. Asia Pacific is a promising region for the squamous non-small cell lung cancer market. In India, approximately 63,000 new lung cancer cases are reported every year and, astonishingly, a significant proportion of these are patients who have no history in smoking. Among female patients, the prime cause of squamous non-small cell lung cancer is regular exposure to smoke from wood or other substitutes for cooking food. Apart from this occupational health hazards are another prime reason for step rise in female lung cancer in Asian countries. Latin America and African countries in terms of revenue is still at nascent stage but due reforms in healthcare infrastructure, lot of pharmaceutical giants have stated focusing on establishing and increasing customer base in the Middle-East countries as well.

Key players in the squamous non-small cell lung cancer market include AstraZeneca plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., OncoGenex Pharmaceuticals, Novartis International AG, and Boehringer Ingelheim GmbH.

Request to view table of content @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=35720

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Squamous Non-small Cell Lung Cancer Market Projected to Grow at a Steady Pace During 2017 – 2025 here

News-ID: 868802 • Views:

More Releases from Transparency Market Research

Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
The latest research study released by Transparency Market Research on "Solid Tires Market Forecast to 2023-2031 ″ research provides accurate economic, global, and country-level predictions and analyses. Solid Tires market is estimated to attain a valuation of US$ 760.0 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.1% during
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031| Says Transparency Market Research
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031 …
The latest research study released by Transparency Market Research on "𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐂𝐲𝐛𝐞𝐫 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Automotive Cyber security industry, as
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from 2022 to 2031: TMR Study
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from …
The latest research study released by Transparency Market Research on "𝐑𝐞𝐚𝐝𝐲-𝐦𝐢𝐱 𝐂𝐨𝐧𝐜𝐫𝐞𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Ready-mix Concrete industry, as well as
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, According to TMR Study
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, Acco …
The latest research study released by Transparency Market Research on "𝐌𝐢𝐧𝐢𝐧𝐠 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Mining Automation industry, as well as

All 5 Releases


More Releases for Lung

Lung Cancer Surgery Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Lung Cancer Surgery Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. This market research study determines the increase in changes and the aspects which are likely to have an impact on the growth of the Lung Cancer Surgery Market. Increased demand for the technologies is also one of the factors, which are likely to boost the growth of this industry. The
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor
11-11-2019 | Health & Medicine
CMI
Higher carcinoma lung population dominates the lung cancer therapeutics market
Lung cancer is a malignant lung tumor, which is characterized by uncontrolled division and growth of cells in the lungs. The ability of lungs to provide oxygen into the bloodstream decreases with increasing size of tumor. The lung carcinoma is classified as, non-small cell and small cell lung cancer and originates from the epithelial cells. Lung cancer has the highest mortality rate globally, where exposure to asbestos, cigarette and pipe
Lung Management Products Market Soaring Demand Assures Motivated Revenue Share d …
Lung management products are required for patients dealing with severe conditions such as asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and lung cancers. Lung management products are also used as a home-based care to exercise lungs and keep them healthy for a longer run. Several lung exercisers are available and being highly preferred. According to the American Lung Association, lung cancer was the most common cancer type in 2015
Artificial Lung Market Key Players 2018 - Haemair Ltd, Lung Biotechnology PBC, a …
Artificial Lung Overview: Medical Devices sector report, “Artificial Lung - Medical Devices Pipeline Assessment, 2018" provides an overview of Artificial Lung currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start
Lung Cancer Vaccine Market Lung Cancer Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents What are Cancer Vaccines? Mechanism of Cancer Vaccines 2.1 Idiotype Cancer Vaccine Mechanism 2.2 Cellular Cancer Vaccines Mechanism 2.3 Ganglioside Antigens based Cancer Vaccines Mechanism 2.4 Peptide Cancer Vaccine Mechanism 2.5 Tumor Host Interaction Cancer Vaccine Mechanism Overview of Lung Cancer Proliferation 3.1 Lung Cancer Invasion 3.1.1 Transformation of Normal Cell into